Southern Capitol Ventures Closes $15M Fund, Plans to Invest in Life Science Tool Shops | GenomeWeb
NEW YORK (GenomeWeb News) – Southern Capitol Ventures, a venture capital firm that focuses on early-stage technology and life science companies in the Southeast and Mid-Atlantic, said today that it has closed on its second fund, worth $15 million.
Investors in the fund include Square 1 Bank, Capitol Broadcasting, and individual investors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.